叙述性评论
听力损失
遗传增强
基因
自然史
医学
临床试验
遗传学
生物
内耳
基因突变
生物信息学
评论文章
听力学
突变
基因检测
分子诊断学
作者
Jenna Devare,Audrey P. Lawrence,John A. Germiller
出处
期刊:Ear and Hearing
[Lippincott Williams & Wilkins]
日期:2026-10-13
卷期号:47 (6): 1543-1551
标识
DOI:10.1097/aud.0000000000001861
摘要
In the last decade, gene therapy has shown promise in treating many genetic disorders. Hereditary hearing impairment represents one of the next promising frontiers. Many initial development efforts have focused on hearing impairment caused by mutations in the otoferlin gene ( OTOF ), as these mutations cause profound deafness in the setting of preserved auditory outer hair cells, which often remain for many years after birth. Animal models have shown that the target cells for gene delivery, the inner hair cells, are also present and viable, and they reside in a structurally intact organ that is otherwise functional. Recent remarkable successes reported with OTOF gene therapy serve as proof of concept that gene therapy can effectively and safely improve hearing for this and likely other forms of genetic deafness. Here, the authors review the otoferlin protein and its role in hearing, the role of pathogenic variants in OTOF in hearing loss, the natural history of the condition, and the results of preclinical studies and of current human clinical trials of OTOF gene therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI